United States · Wires & real time · Bloomberg
All-or-Nothing Biotech Bets Dented by Rising Treasury Yields
Investors are beginning to turn cautious on biotechnology stocks as a rapid rise in Treasury yields dents the appeal for shares of companies that are often viewed as risky…
Read the full article on Bloomberg Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.bloomberg.com)
